Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D.T. Cheng, J. Niewoehner, M. Dahl, A. Tsai, W. Gonsiorek, C. Ma, S. Apparsundaram, A. Pashine, P. Ravindran, J. Jung, J. Allard, H. Bitter, C. Tribouley, S. Wilson, M.E. Fuentes (Nutley, Shrewsbury, United States Of America; Penzberg, Germany). Blockade of thymic stromal lymphopoietin receptor (TSLPR) reduces atopic inflammation in a cynomolgus monkey model of asthma. Eur Respir J 2012; 40: Suppl. 56, 2329

Member's Comments

No comment yet.

Related content which might interest you: FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells Source: Eur Respir J 2009; 33: 425-435 Year: 2009 Serum thymic stromal lymphopoietin level depends on allergic profile in pediatric asthma Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies Year: 2021 IL-4Ra signaling is required for thymic stromal lymphopoietin (TSLP)-induced type 2 airway inflammation Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021 Thymic stromal lymphopoietin (TSLP) as a local biomarker of hypertrophic changes in the synonasal mucosa in children with atopic bronchial asthma (BA) and allergic rhinitis (AR) Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 ILC2 cells from severe allergic and eosinophilic asthma demonstrate increased expression of TSLP receptor (TSLPR) and enhanced proliferative capacity. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 Thymic stromal lymphopoietin, but not ezrin, could be an early biomarker of airway epithelial dysfunction in acute allergic asthma Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march Source: Eur Respir Rev 2014; 23: 292-298 Year: 2014 Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin Source: International Congress 2018 – Roles of innate lymphoid cells in asthma Year: 2018 Thymic stromal lymphopoietin (TSLP) in naturally occurring asthma exacerbations in adults Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Thymic stromal lymphopoietin (TSLP), an innate immunity initiator of Th2 inflammatory responses, is induced by viral stimuli in asthmatic epithelium. Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008 Peripheral blood TSLP (thymic stromal lymphopoietin) in children as a biomarker? Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021 Thymic stromal lymphopoietin promotes asthmatic airway remodeling in human lung fibroblast cells through stat3 signaling pathway Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 Analysing disease-specific variants of thymic stromal lymphopoietin (TSLP) in asthma Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Vanadium pentoxide induced epithelial innate cytokines IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) through activating MAPK pathway Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 A fully dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a murine model of asthma Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 The Cys-LT1 receptor antagonist, pranlukast, attenuates allergen-induced increase in airway eosinophils and bone marrow derived eosinophil/basophil progenitors in subjects with atopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 349s Year: 2003 Inhaled antibodies: targeting tumour necrosis factor receptor 1 and thymic stromal lymphopoietin Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019 IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor. Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Role of CCL21 and CCL19 in allergic inflammation examined by murine asthmatic model Source: Annual Congress 2006 - Immunology of the airways Year: 2006 Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010